Portfolio Company:

Peptilogics

Combating the growing global epidemic from multidrug-resistant infections

Peptilogics develops novel therapeutic solutions using rationally designed peptide antibiotics that kill anti-biotic resistant bacteria. The platform technology has many applications in advanced woundcare, cystic fibrosis and biodefense.

Portfolio news